22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay
- PMID: 17926345
- DOI: 10.1002/ajmg.c.30155
22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay
Abstract
The 22q13.3 deletion syndrome is a recognizable malformation syndrome associated with developmental delay, hypotonia, delayed or absent speech, autistic-like behavior, normal to accelerated growth and dysmorphic facies. The prevalence of this disorder is unknown, but it is likely under-diagnosed. Age at diagnosis has varied widely, from cases diagnosed prenatally to 46 years. Males and females are equally affected. The distal 22q deletion can be detected occasionally by routine or high resolution chromosome analysis; however, the majority of cases are detected by FISH analysis, associated with deletion of the ARSA (control) probe when performing a FISH analysis for the velocardiofacial syndrome (del 22q11.2). The 22q13.3 deletion syndrome can accompany a simple chromosome deletion, an unbalanced translocation, or a ring chromosome. Primary care physicians, in addition to numerous specialists, play an important role in caring for patients with this disorder. Although the dysmorphic features observed in this condition are nonspecific, it is an important consideration in the differential diagnosis of children with developmental delay, hypotonia, marked speech and language disability, autistic-like features, multiple minor anomalies, and normal growth and head circumference.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood.Pediatrics. 2008 Aug;122(2):e376-82. doi: 10.1542/peds.2007-2584. Epub 2008 Jul 14. Pediatrics. 2008. PMID: 18625665
-
Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.Eur J Hum Genet. 2005 Sep;13(9):1019-24. doi: 10.1038/sj.ejhg.5201456. Eur J Hum Genet. 2005. PMID: 15986041
-
Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).J Med Genet. 2011 Nov;48(11):761-6. doi: 10.1136/jmedgenet-2011-100225. Epub 2011 Oct 7. J Med Genet. 2011. PMID: 21984749
-
Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH.Am J Med Genet. 2000 Dec 4;96(6):839-44. Am J Med Genet. 2000. PMID: 11121193 Review.
-
Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.Immunol Allergy Clin North Am. 2008 May;28(2):353-66. doi: 10.1016/j.iac.2008.01.003. Immunol Allergy Clin North Am. 2008. PMID: 18424337 Review.
Cited by
-
Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the Shank3 Gene.eNeuro. 2018 Oct 5;5(3):ENEURO.0046-18.2018. doi: 10.1523/ENEURO.0046-18.2018. eCollection 2018 May-Jun. eNeuro. 2018. PMID: 30302388 Free PMC article.
-
Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment.PLoS One. 2019 Mar 15;14(3):e0213921. doi: 10.1371/journal.pone.0213921. eCollection 2019. PLoS One. 2019. PMID: 30875393 Free PMC article.
-
Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.Mol Syndromol. 2020 Jan;10(6):294-305. doi: 10.1159/000503840. Epub 2019 Nov 5. Mol Syndromol. 2020. PMID: 32021603 Free PMC article.
-
Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation.BMC Med Genet. 2010 May 11;11:72. doi: 10.1186/1471-2350-11-72. BMC Med Genet. 2010. PMID: 20459802 Free PMC article.
-
Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency.Mol Autism. 2013 Jun 11;4(1):18. doi: 10.1186/2040-2392-4-18. Mol Autism. 2013. PMID: 23758760 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical